Long-term outcomes in cancer patients who did or did not pursue fertility preservation.
Ontology highlight
ABSTRACT: OBJECTIVE:To compare long-term outcomes of cancer patients who pursued fertility preservation (FP) with those who did not and compare random-start (RS) and menstrual cycle-specific (CS) protocols for FP. DESIGN:Retrospective cohort. SETTING:Single urban academic institution. PATIENT(S):Oncology patients who contacted the FP patient navigator, 2005-2015. INTERVENTION(S):None. MAIN OUTCOME MEASURE(S):Time to cancer treatment, disease-free survival, and reproductive outcomes in FP versus no-FP patients and cycle outcomes for RS versus CS protocols. Data were analyzed by ?2 and logistic regression. RESULT(S):Of 497 patients who met the inclusion criteria, 41% elected FP. The median number of days to cancer treatment was 33 and 19 days in the FP and no-FP groups, respectively. There was no difference in cancer recurrence or mortality. There were no differences in stimulation parameters, outcomes, or days to next cancer treatment in RS versus CS protocols. Twenty-one patients returned to use cryopreserved specimens, resulting in 16 live births. Eight of 21 returning patients used a gestational carrier. Thirteen FP (6.4%) and 16 no-FP (5.5%) patients experienced a spontaneous pregnancy. CONCLUSION(S):FP is both safe and efficacious for eligible cancer patients. Only 10% of patients returned to use cryopreserved specimens, and almost half used a gestational carrier, suggesting the need for further research into reproductive decision-making in cancer survivors.
SUBMITTER: Moravek MB
PROVIDER: S-EPMC5815903 | biostudies-literature | 2018 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA